ReviewPeerJ2026
Regulatory mechanisms of hypoxia-inducible factors on ferroptosis in ischemic stroke.
Review in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ischemic stroke remains a primary contributor to global disability and mortality, primarily resulting from interruptions in cerebral blood flow that trigger brain tissue necrosis. Among the various mechanisms of cell death, ferroptosis assumes a key role in the pathophysiology of cerebral infarction. Hypoxia-inducible factors (HIFs) are central to cellular adaptation under hypoxic conditions and exhibits dual regulatory roles in neuronal ferroptosis. This review delineates the intricate mechanisms by which HIF-1α and the less-characterized HIF-3α modulate ferroptosis in ischemic stroke. We detail how HIF-1α promotes ferroptosis by disrupting iron homeostasis, amplifying lipid peroxidation, and activating inflammatory networks, while also highlighting its context-dependent protective functions. Furthermore, we explore the emerging role of HIF-3α, particularly its mitochondrial localization and diverse functions conferred by alternative splicing variants, which may oppose HIF-1α-driven ferroptosis. By synthesizing the distinct regulatory networks of HIF-1α and HIF-3α, this review underscores their potential as therapeutic targets and proposes that selective modulation of these pathways could offer novel neuroprotective strategies for ischemic stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.